SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism

Circulation. 2022 Sep 13;146(11):819-821. doi: 10.1161/CIRCULATIONAHA.122.060805. Epub 2022 Sep 12.
No abstract available

Keywords: Editorials; clinical trial; heart failure; metabolism; metabolomics; pharmacology.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Heart Failure* / drug therapy
  • Heart Failure* / metabolism
  • Humans
  • Metabolomics
  • Sodium-Glucose Transporter 2 Inhibitors* / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors